200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 174655-06-2

174655-06-2

174655-06-2 | Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[(1-naphthalenylamino)methyl]-

CAS No: 174655-06-2 Catalog No: AG001ZUU MDL No:

Product Description

Catalog Number:
AG001ZUU
Chemical Name:
Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[(1-naphthalenylamino)methyl]-
CAS Number:
174655-06-2
Molecular Formula:
C18H16N6
Molecular Weight:
316.3598
IUPAC Name:
6-[(naphthalen-1-ylamino)methyl]pyrido[2,3-d]pyrimidine-2,4-diamine
InChI:
InChI=1S/C18H16N6/c19-16-14-8-11(10-22-17(14)24-18(20)23-16)9-21-15-7-3-5-12-4-1-2-6-13(12)15/h1-8,10,21H,9H2,(H4,19,20,22,23,24)
InChI Key:
BBVNYSAAUUALLQ-UHFFFAOYSA-N
SMILES:
Nc1nc(N)c2c(n1)ncc(c2)CNc1cccc2c1cccc2

Properties

Complexity:
418  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
316.144g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
316.368g/mol
Monoisotopic Mass:
316.144g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
103A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.8  

Literature

Title Journal
Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Journal of medicinal chemistry 20031106
Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase. Journal of medicinal chemistry 20020103
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations. Journal of medicinal chemistry 19960315

Related Products

© 2019 Angene International Limited. All rights Reserved.